Schwartz-Porsche, D (1986) Epidemiological, clinical and pharmacokinetic studies in spontaneously epileptic dogs and cats. ACVIM
Kearsley-Fleet, L, O’Neill, DG, Volk, HA, et al. (2013) Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Vet Rec
Casal, ML, Munuve, RM, Janis, MA, et al. (2006) Epilepsy in Irish Wolfhounds. J Vet Intern Med
Berendt, M, Gulløv, CH & Fredholm, M (2009) Focal epilepsy in the Belgian shepherd: evidence for simple Mendelian inheritance. J Small Anim Pract
Engel, JJ & Pedley, TA (1997) Introduction. What is epilepsy? In Epilepsy: A Comprehensive Textbook (Vol 1), pp. 1–10. New York: Lipponcott-Raven.
Kwan, P, Schachter, SC & Brodie, MJ (2011) Drug-resistant epilepsy. N Engl J Med
Zweiri, MA, Sills, GJ, Leach, JP, et al. (2010) Response to drug treatment in newly diagnosed epilepsy: a pilot study of 1H NMR- and MS-based metabonomic analysis. Epilepsy Res
Hitiris, N, Mohanraj, R, Norrie, J, et al. (2007) Predictors of pharmacoresistant epilepsy. Epilepsy Res
Löscher, W (1997) Animal models of intractable epilepsy. Prog Neurobiol
Volk, HA, Matiasek, LA, Feliu-Pascual, LA, et al. (2008) The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Vet J
Thomas, WB (2010) Idiopathic epilepsy in dogs and cats. Vet Clin N Am Small Anim Pract
Dewey, CW (2006) Anticonvulsant therapy in dogs and cats. Vet Clin N Am Small Anim Pract
Thigpen, J, Miller, SE & Pond, BB (2013) Behavioural side effects of antiepileptic drugs. US Pharm
Lowrie, M (2012) Advances in the management of idiopathic epilepsy in dogs. Companion Animals
Martlé, V, Ham, LV, Raedt, R, et al. (2013) Non-pharmacological treatment options for refractory epilepsy: An overview of human treatment modalities and their potential utility in dogs. Vet J
Wilder, RM (1921) The effects of ketonemia on the course of epilepsy. Mayo Clin Proc
Geyelin, HR (1921) Fasting as a method of treating epilepsy. Med Rec
Neal, EG, Chaffe, H, Schwartz, RH, et al. (2008) The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol
Schwartz, RH, Eaton, J, Bower, BD, et al. (1989) Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Dev Med Child Neurol
Vining, EPG, Freeman, JM, Ballaban-Gil, K, et al. (1998) A multicenter study of the efficacy of the ketogenic diet. Arch Neurol
Thavendiranathan, P, Chow, C, Cunnane, S, et al. (2003) The effect of the ‘classic’ ketogenic diet on animal seizure models. Brain Res
Suo, C, Liao, J, Lu, X, et al. (2013) Efficacy and safety of the ketogenic diet in Chinese children. Seizure
Kossoff, EH, McGrogan, JR, Bluml, RM, et al. (2006) A modified atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia
Huttenlocher, PR, Wilbourn, AJ & Signore, JM (1971) Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology
Neal, EG, Chaffe, H, Schwartz, RH, et al. (2009) A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia
Pfeifer, HH & Thiele, EA (2005) Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology
Yuen, AWC & Sander, JW (2014) Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy. Epilepsy Behav
Sills, MA, Forsythe, WI, Haidukewych, D, et al. (1986) The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child
Puchowicz, MA, Smith, CL, Bomont, C, et al. (2000) Dog model of therapeutic ketosis induced by oral administration of R,S-1,3-butanediol diacetoacetate. J Nutr Biochem
Kelley, SA & Hartman, AL (2011) Metabolic treatments for intractable epilepsy. Semin Pediatr Neurol
Liu, YMC (2008) Medium chain triglyceride (MCT) ketogenic therapy. Epilepsia
49, Suppl. 8, 33–36.
Trauner, DA (1985) Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology
Pan, Y, Larson, B, Araujo, JA, et al. (2010) Dietary supplementation with medium-chain TAG has long lasting cognition-enhancing effects in aged dogs. Br J Nutr
Licht, BG, Licht, MH, Harper, KM, et al. (2002) Clinical presentations of naturally occurring canine seizures: similarities to human seizures. Epilepsy Behav
Potschka, H, Fischer, A, Rüden, VEL, et al. (2013) Canine epilepsy as a translational model?
Patterson, EE, Muñana, KK, Kirk, CA, et al. (2005) Results of a ketogenic food trial for dogs with idiopathic epilepsy. J Vet Intern Med
Giordano, C, Marchiò, M, Timofeeva, E, et al. (2014) Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol
Masino, SA & Rho, JM (2012) Mechanisms of ketogenic diet action. In Jasper’s Basic Mechanisms of the Epilepsies, 4th ed. pp. 1001–1022 [JL Noebels, M Avoli and MA Rogawski, editors]. Bethesda, MD: National Center of Biotechnology Information (US).
Rho, JM & Sankar, R (2008) The ketogenic diet in a pill: is this possible?
49, Suppl. 8, 127–133.
Bough, KJ & Rho, JM (2007) Anticonvulsant mechanisms of the ketogenic diet. Epilepsia
48, 1, 43–58.
Coppola, G, Verrotti, A, D’Aniello, A, et al. (2010) Valporic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet. Acta Neurol Scand
Dahlin, MG, Beck, OML & Åmark, PE (2006) Plasma levels of antiepileptic drugs in children on the ketogenic diet. Neurol
McNally, MA & Hartman, AL (2012) Ketone bodies in epilepsy. J. Neurochem
Gilbert, DL, Pyzik, PL & Freeman, JM (2000) The ketogenic diet: seizure control correlates with serum β-hydroxybutyrate than with urine ketosis. J Child Neurol
Keith, H (1935) Experimental convulsions induced by administration of thujone. Arch NeurPsych
Rho, JM, Anderson, GD, Donevan, SD, et al. (2002) Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)- beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo
Likhodii, SS, Serbanescu, I, Cortez, MA, et al. (2003) Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet.
Gasior, M, French, A, Joy, MT, et al. (2007) The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia
Greene, A, Todorova, MT & Seyfried, TN (2003) Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem
Piotr, W, Socała, K, Nieoczym, D, et al. (2012) Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice. Neuropharmacology
Piotr, W, Socała, K, Nieoczym, D, et al. (2015) Acute anticonvulsant effects of capric acid in seizure tests in mice. Prog Neuropsychopharmacol Biol Psychiatry
Chang, P, Terback, N, Plant, N, et al. (2013) Seizure control by ketogenic diet-associated medium chain fatty acids. Neuropharmacology
Chang, P, Orabi, B, Deranieh, RM, et al. (2012) The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyistelium
. Dis Model Mech
Chang, P, Walker, M & Williams, RSB (2014) Seizure-induced reduction in PIP3 levels contributes to seizure activity and is rescued by valporic acid. Neurobiol Dis
Chang, P, Zuckerman, AME, Williams, S, et al. (2015) Seizure Control by Derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency. J Pharmacol Exp Ther
Muñana, KR, Zhang, D & Patterson, EE (2010) Placebo effect in canine epilepsy trials. J Vet Intern Med